Free Trial

Short Interest in iHuman Inc. Sponsored ADR (NYSE:IH) Increases By 150.0%

iHuman logo with Consumer Discretionary background

Key Points

  • Short interest in iHuman Inc. increased by 150.0% in September, rising to 500 shares from 200 shares at the end of August.
  • Several institutional investors have recently increased their stakes in iHuman, with Citadel Advisors LLC raising its holdings by 24.3%.
  • iHuman's stock rose by 0.9% to $2.96, with a market capitalization of $153.72 million and a reported earnings per share of $0.08.
  • Interested in iHuman? Here are five stocks we like better.

iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totaling 500 shares, an increase of 150.0% from the August 31st total of 200 shares. Based on an average daily volume of 33,900 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily volume of 33,900 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Investors Weigh In On iHuman

Several institutional investors and hedge funds have recently bought and sold shares of the business. Citadel Advisors LLC increased its holdings in iHuman by 24.3% in the 4th quarter. Citadel Advisors LLC now owns 47,683 shares of the company's stock valued at $81,000 after buying an additional 9,314 shares during the period. Virtu Financial LLC bought a new stake in iHuman in the 1st quarter valued at $26,000. Finally, Acadian Asset Management LLC bought a new stake in iHuman in the 1st quarter valued at $32,000. Institutional investors own 4.92% of the company's stock.

iHuman Stock Up 0.9%

Shares of NYSE:IH traded up $0.03 during trading on Friday, reaching $2.96. The stock had a trading volume of 15,209 shares, compared to its average volume of 41,513. iHuman has a 52 week low of $1.47 and a 52 week high of $3.60. The firm has a market capitalization of $153.72 million, a price-to-earnings ratio of 10.19 and a beta of 0.40. The stock has a fifty day simple moving average of $2.84 and a two-hundred day simple moving average of $2.50.

iHuman (NYSE:IH - Get Free Report) last announced its earnings results on Thursday, September 18th. The company reported $0.08 earnings per share (EPS) for the quarter. iHuman had a net margin of 12.46% and a return on equity of 11.59%. The business had revenue of $27.94 million for the quarter.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a "hold (c+)" rating on shares of iHuman in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of "Hold".

Check Out Our Latest Stock Report on IH

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in iHuman Right Now?

Before you consider iHuman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.

While iHuman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.